Granahan Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.21M	Sell	958,493 -682,300	-42%	-$1.58M	0.09%	132
2025 Q1	$2.28M	Buy	1,640,793 +4,412	+0.3%	+$6.13K	0.11%	132
2024 Q4	$2.83M	Buy	1,636,381 +496,482	+44%	+$859K	0.12%	138
2024 Q3	$2.29M	Buy	1,139,899 +330,208	+41%	+$664K	0.09%	164
2024 Q2	$1.81M	Buy	+809,691	New	+$1.81M	0.07%	160